Network News
Yesterday (October 16, 2024), NMI employee Dr. Nicole Anderle was awarded the Reinhold-und-Maria Teufel Foundation Prize for her doctorate on precision oncology. The prize is endowed with 5,000 euros and was presented to the scientist at the foundation’s headquarters in Tuttlingen. The challenges in cancer therapy are immense, especially the resistance to therapy in patients […]
read more
Federal Government appoints Professor Eva Winkler to the German Ethics Council
The German Ethics Council is an expert body that advises parliament and government on social and, above all, medical and bioethical issues. Eva Winkler, Heisenberg Professor for Translational Medical Ethics at the Heidelberg Faculty of Medicine of Heidelberg University, has now been appointed to the Council. As Managing Director at the National Centre for Tumour […]
read more
U.S. FDA Approves VYALEV™ (foscarbidopa and foslevodopa) for Adults Living with Advanced Parkinson’s Disease
NORTH CHICAGO, Ill., Oct. 17, 2024 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved VYALEV™ (foscarbidopa and foslevodopa) as the first and only subcutaneous 24-hour infusion of levodopa-based therapy for the treatment of motor fluctuations in adults with advanced Parkinson’s disease (PD). “For too long, the Parkinson’s community has had […]
read more
BOTOX® Cosmetic (onabotulinumtoxinA) Receives FDA Approval for Moderate to Severe Vertical Bands Connecting the Jaw and Neck (Platysma Bands)
IRVINE, Calif., Oct. 18, 2024 /PRNewswire/ — Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced the U.S. FDA approval of BOTOX® Cosmetic for temporary improvement in the appearance of moderate to severe vertical bands connecting the jaw and neck (platysma bands) in adults.1 BOTOX® Cosmetic is the first and only product with four aesthetic indication areas: forehead lines, frown lines, […]
read more
The cellular superhero that protects us against RNA viruses
Scientists have discovered how the antiviral protein TRIM25 finds and binds viral RNA to activate an immune response Summary Every second of every day, our body is under attack. The invading agents are viruses, bacteria, parasites, toxins – living and non-living entities that might negatively impact our body’s functioning. What keeps us safe is a […]
read more
Awards for young scientists from Heidelberg
Ruprecht Karls Prizes and Fritz Grunebaum Prize to be awarded on October 25 The Heidelberg University Foundation honors young academics with the Ruprecht Karls Prizes for their outstanding scientific publications. The awards go to five doctoral students from various disciplines. The Fritz Grunebaum Prize will also be awarded during the festive event in the auditorium […]
read more
New Member: Welcome in our cluster to Pitchload GmbH
Pitchload’s goal is to make innovation ecosystems more transparent, accessible, and efficient. Startups and accelerators currently waste time maintaining databases and creating PDFs. Pitchload’s mission is to create a “single source of truth” for the European innovation ecosystem, starting locally but aiming globally. Pitchload offers streamlined information sharing, syncing with third-party systems, and privacy control […]
read more
How do rare genetic variants affect health? AI provides more accurate predictions
Whether we are predisposed to particular diseases depends to a large extent on the countless variants in our genome. However, particularly in the case of genetic variants that only rarely occur in the population, the influence on the presentation of certain pathological traits has so far been difficult to determine. Researchers from the German Cancer […]
read more
Life Sciences Bridge Award for Dr Vivek Thacker
Every year, more than a million people die from tuberculosis. To date, there is no effective vaccination against the pathogen, and treatment is also lengthy and difficult due to increasing multiple resistances. As the bacterium Mycobacterium tuberculosis manages to defy both the immune system and antibiotic treatment, Dr. Vivek Thacker, group leader at the Medical Faculty Heidelberg […]
read more
